Vista Dental Products

	SmearOFF™ by Vista Dental Products offers multiple benefits in one product, including removing smear layer and bacteria.

 effectively replaces two commonly used solutions: EDTA and CHX. SmearOFF™ is an EDTA based formula enhanced with Chlorhexidine. SmearOFF™ not only effectively removes the smear layer, but also kills bacteria in one easy step.

More from Vista Dental Products: Vista Dental introduces new Brite-N-Lite Oral Illumination System

	SmearOFF™ removes significantly more canal debris compared to standard 17 percent EDTA, and leaves the root canal surface cleaner by opening a greater percentage of dentin tubules. Additionally, SmearOFF™ provides the added benefit of killing root canal bacteria.

	Unlike other 2-in-1 mixes, SmearOFF™ is compatible with Sodium Hypochlorite and will not form a precipitate; eliminating steps and saving time with each procedure.

More from Vista Dental Products: Make composite placement easier with new Therma-Flo warming kit

		Will not form a precipatae when mixed with NaOCl

		Superior chelation and enhanced cleansing

		Reportedly kills 99.99 percent of bacteria in 10 seconds*

		Reported 30 percent savings compared to other leading brands

*Independently confirmed by Nelson Labs; time kill study protocol #STP0158.2

Articles

SmearOFF™ by Vista Dental Products offers multiple benefits in one product, including removing smear layer and bacteria.

Vista Dental Products' SmearOff offers multiple benefits in one product

	Visual Solutions, a wholly owned subsidiary of 

, is focused on developing transformative life changing technologies for cancer screening, detection and intervention through the use of molecular markers.

	Drawing on eight years of research, development and clinical studies, the company introduced the ESPyOC™ oral cancer screening system. ESPyOC™ is said to be a game-changer in the way the dental and medical community visualizes oral cancer. It is designed as a simple, cost-effective and noninvasive chairside test that provides immediate results for patients with suspicious lesions.

	Utilizing a unique patent-pending biomarker approach, ESPyOC™ demonstrated 99 percent sensitivity and 85 percent specificity for oral cancer detection in mrore than 120 patients and accurately detected 79 percent of precancerous lesions.

Related reading: The importance of oral cancer screening in the dental practice

Visual Solutions, a wholly owned subsidiary of Vista Dental Products, is focused on developing transformative life changing technologies for cancer screening, detection and intervention through the use of molecular markers.